Literature DB >> 14767779

Cathepsins in basal cell carcinomas: activity, immunoreactivity and mRNA staining of cathepsins B, D, H and L.

Eleonore Fröhlich1, Matthias Möhrle, C Klessen.   

Abstract

In the majority of neoplasms invasion is inevitably linked to metastasis and even small tumors have the dormant potential for metastasis. In basal cell carcinoma (BCC) invasion can be evaluated separately because local invasion but no metastasis occurs. Important proteases in invasion and metastasis are the cathepsins. Their activity and regulation has not yet been evaluated in BCC. We determined the activities, immunoreactivities and mRNA of cathepsins B, L and H in sections of different subtypes of BCC. BCC cells and peritumoral cells contained activities for cathepsins B and L. In all parts of the tumor, the reaction with cathepsin B and L substrate was stronger than in normal skin. The immunoreactive protein and mRNA for these proteases, in contrast, was elevated only occasionally in small tumor nodules. Immunoreactive protein and mRNA of cathepsin D was detected predominantly in the center of tumor nodules. Cathepsin H activities, immunoreactivities and mRNA in most BCCs were higher than in normal skin, and the reactive cells were located between and around tumor nodules, but not in the tumor nests. The results indicate that cathepsins B and L are involved in invasion of BCC cells. Cathepsin H of the peritumoral cells may either promote invasion of the tumor cells by degradation of the extracellular matrix or may reflect an elevated activity of the surrounding immunological cells. The pattern of cathepsin staining markedly differs from that observed in melanomas and may characterize locally invading non-metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14767779     DOI: 10.1007/s00403-003-0449-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  6 in total

Review 1.  Proteases in cutaneous malignant melanoma: relevance as biomarker and therapeutic target.

Authors:  Eleonore Fröhlich
Journal:  Cell Mol Life Sci       Date:  2010-08-05       Impact factor: 9.261

2.  Rapid visualization of nonmelanoma skin cancer.

Authors:  Ethan Walker; Margaret Mann; Kord Honda; Allison Vidimos; Mark D Schluchter; Brian Straight; Matthew Bogyo; Daniel Popkin; James P Basilion
Journal:  J Am Acad Dermatol       Date:  2016-11-19       Impact factor: 11.527

3.  Molecular imaging and validation of margins in surgically excised nonmelanoma skin cancer specimens.

Authors:  Yiqiao Liu; Ethan Walker; Sukanya Raj Iyer; Mark Biro; InYoung Kim; Bo Zhou; Brian Straight; Matthew Bogyo; James P Basilion; Daniel L Popkin; David L Wilson
Journal:  J Med Imaging (Bellingham)       Date:  2019-03-18

4.  Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment.

Authors:  Ghada Abboud-Jarrous; Ruth Atzmon; Tamar Peretz; Carmela Palermo; Bedrick B Gadea; Johanna A Joyce; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2008-04-30       Impact factor: 5.157

5.  Favorable Prognostic Impact of Cathepsin H (CTSH) High Expression in Thyroid Carcinoma.

Authors:  Pai Peng; Jiang-Yuan Chen; Kai Zheng; Chao-Hua Hu; Yun-Tao Han
Journal:  Int J Gen Med       Date:  2021-09-07

6.  Cathepsin L increases invasion and migration of B16 melanoma.

Authors:  Zhen Yang; James L Cox
Journal:  Cancer Cell Int       Date:  2007-05-08       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.